Patents Examined by T. Cummingham
  • Systemic treatment of metastatic cancer with platelet factor 4
    Patent number: 5284827
    Abstract: The subject invention concerns a novel treatment for cancer. Specifically, the invention concerns the systemic administration of recombinant Platelet Factor Four (rPF4) to inhibit tumor growth in a mammal having metastatic cancer.
    Type: Grant
    Filed: October 19, 1990
    Date of Patent: February 8, 1994
    Assignee: Repligen Corporation
    Inventors: Theodore Maione, Richard J. Sharpe